Keyphrases
Adoptive Immunotherapy
35%
Autologous Tumors
11%
Breast
18%
Breast Cancer
44%
Breast Cancer Patients
15%
Breast Reconstruction
29%
Cancer Immunotherapy
12%
Cancer Patients
10%
CD4+
20%
CD8+ T Cells
18%
Cellular Factors
12%
Conservative Surgery
11%
Cytotoxic T Lymphocytes
38%
Cytotoxicity
19%
Dendritic Cells
19%
Derived Peptide
13%
Early Breast Cancer
15%
Her2neu
40%
HLA-A2
33%
Human Tumors
16%
Interleukin-2
55%
Local Recurrence
24%
Lymphocytes
15%
Lymphoid Cells
17%
Lymphokine-activated Killer Cells
20%
Lysis
12%
Mastectomy
14%
Melanoma
12%
Mouse Mammary Tumor
11%
Murine Tumors
14%
Ovarian Cancer
28%
Pancreatic Adenocarcinoma
11%
Pancreatic Cancer
21%
Prognostic Factors
11%
Radiation Therapy
20%
Recombinant interleukin-2
16%
Solid Phase
11%
Surgery Therapy
12%
Surgical Training
11%
Syngeneic
17%
T Cell Receptor
11%
T Cells
52%
Treg
17%
Tumor
89%
Tumor Antigen
32%
Tumor Cells
38%
Tumor Growth
11%
Tumor-associated Lymphocytes
14%
Tumor-infiltrating Lymphocytes
68%
Tumor-specific
34%
Medicine and Dentistry
Adoptive Immunotherapy
16%
Biopsy Technique
13%
Breast Cancer
94%
Breast Reconstruction
11%
Breast Tumor
10%
Cancer
17%
Cancer Cell
10%
Cell Line
11%
Clinical Trial
8%
Connective Tissue Cancer
7%
Cytotoxic T-Cell
43%
Cytotoxicity
18%
Diseases
15%
Drug Megadose
11%
General Surgery
7%
Immunotherapy
14%
In Vitro
26%
Interleukin 2
28%
Interstitial Brachytherapy
13%
Lymphocyte
20%
Malignant Neoplasm
29%
Mastectomy
22%
Medicine
8%
Melanoma
14%
Metastatic Carcinoma
12%
Neoadjuvant Chemotherapy
8%
Neoplasm
100%
Ovarian Cancer
25%
Ovarian Tumor
10%
Overall Survival
9%
Pancreas Cancer
29%
Primary Tumor
7%
Prognostic Factor
9%
Prospective Study
9%
Quadrantectomy
14%
Radiation Therapy
21%
Recurrent Disease
44%
Regulatory T Cell
10%
Sentinel Lymph Node Biopsy
9%
Soft Tissue Sarcoma
13%
Specific Tumor
24%
Surgeon
16%
Surgery
20%
T Cell
27%
T Lymphocyte
9%
T Lymphocyte Receptor
7%
Tumor Antigen
19%
Tumor Cell
30%
Tumor Infiltrating Lymphocyte
22%
Tumor Vaccine
10%
Immunology and Microbiology
Adoptive Immunotherapy
23%
Antigen-Presenting Cell
7%
Cancer Cell
18%
Carcinoma Cell
11%
CD3 Antibody
8%
CD3 Antigen
17%
CD4
32%
CD8
18%
Cell Line
19%
Cyclophosphamide
9%
Cytokine
18%
Cytokine Production
9%
Cytotoxic T Cell
31%
Cytotoxic T-Cell
18%
Cytotoxicity
30%
Dendritic Cell
23%
Epitope
9%
HER2/neu
21%
Human Leukocyte Antigen
8%
Immune Response
9%
Immunotherapy
32%
Innate Lymphoid Cell
13%
interferon
9%
Interleukin 2
65%
Interleukin 4
8%
Low Drug Dose
11%
Lymph Node
8%
Lymphocyte
18%
Lymphoid Cell Line
8%
Lymphokine Activated Killer Cell
16%
Melanoma Cell
7%
Pancreas
15%
Peptides
30%
Prevalence
9%
Programmed Cell Death
7%
Recombinant Interleukin 2
16%
Regulatory T Cell
19%
Secretion (Process)
7%
Solid
11%
Syngenic
17%
T Cell
69%
T Cell Receptor
15%
T Helper Cell
7%
T-Helper Cell
19%
Tumor Antigen
26%
Tumor Cell
42%
Tumor Vaccine
10%
Tumor-Associated Macrophage
22%
Tumor-Infiltrating Lymphocytes
58%
Wild Type
10%